Precision Medicine / Biomarkers
With laboratory services that span the development lifecycle and industry-leading scientists with extensive drug development experience, IQVIA Laboratories can help you simplify and align co-development strategies to speed development and increase probability of regulatory and commercial success.
Our services include:
Assay Development
With the rise of personalized medicine, drug developers are relying more on novel biomarkers from assay development companies to improve their success.
Companion Diagnostics
We have extensive companion diagnostics experience across the world, including APAC, China, EMEA and US, and we have generated lab data supporting multiple successful CDx submissions and more than 150 CDx clinical trials engagements.
Cell and Gene Therapies
With our industry-leading science and innovative solutions, we have experience partnering with clients to advance development of their cell and gene therapy trials across numerous indications and development phases.
Enterprise Biomarker Services
Expertise, experience, and tools for an optimized biomarker strategy throughout your product’s development life cycle.
Related Services
Anatomic Pathology Laboratory Services
Learn more
Bioanalytical Services
Learn more
ADME / DMPK Services
Learn more
Biomarker Services
Learn more
Biotech Laboratory Solutions
Learn more
Central Laboratory Services
Learn more
Clinical Genomics Laboratory Services
Learn more
Companion Diagnostics (CDx)
Learn more
COVID-19 Clinical Trial Solutions
Learn more
Flow Cytometry Assay Development
Learn more
Translational Science and Innovations Laboratory Services (TSAIL)
Learn more
